0000939767-18-000116.txt : 20180601 0000939767-18-000116.hdr.sgml : 20180601 20180601195945 ACCESSION NUMBER: 0000939767-18-000116 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180530 FILED AS OF DATE: 20180601 DATE AS OF CHANGE: 20180601 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FELDBAUM CARL B CENTRAL INDEX KEY: 0001326377 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30235 FILM NUMBER: 18876654 MAIL ADDRESS: STREET 1: C/O EXELIXIS INC STREET 2: 170 HARBOR WAY, PO BOX 511 CITY: SOUTH SAN FRISCISCO STATE: CA ZIP: 94083-0511 FORMER NAME: FORMER CONFORMED NAME: Feldbaum Carl B DATE OF NAME CHANGE: 20050506 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXELIXIS, INC. CENTRAL INDEX KEY: 0000939767 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043257395 STATE OF INCORPORATION: DE FISCAL YEAR END: 0102 BUSINESS ADDRESS: STREET 1: 210 E. GRAND AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508377000 MAIL ADDRESS: STREET 1: 210 E. GRAND AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS INC DATE OF NAME CHANGE: 20000207 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20000106 4 1 wf-form4_152789757102712.xml FORM 4 X0306 4 2018-05-30 0 0000939767 EXELIXIS, INC. EXEL 0001326377 FELDBAUM CARL B C/O EXELIXIS, INC. 210 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Common Stock 2018-05-30 4 M 0 11250 4.16 A 45983 D Common Stock 2018-05-30 4 M 0 3500 4.57 A 49483 D Common Stock 2018-05-30 4 S 0 34262 20.60 D 15221 D Option (right to buy) 4.16 2018-05-30 4 M 0 11250 0 D 2009-05-14 2019-05-13 Common Stock 11250.0 0 D Option (right to buy) 4.57 2018-05-30 4 M 0 3500 0 D 2012-05-24 2019-05-23 Common Stock 3500.0 11500 D Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.57 to $20.68. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. The option, representing the right to purchase a total of 11,250 shares of Exelixis, Inc. common stock, became fully exercisable on May 14, 2009. The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 24, 2012. /s/ Jennifer Drimmer Rokovich, Attorney in Fact 2018-06-01